SOW
ITOS

State of Wyoming’s iTeos Therapeutics ITOS Stock Holding History

State of Wyoming’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,320
Closed -$33.9K – 1731
2024
Q3 		$33.9K Buy
+3,320
New +$50.6K ﹤0.01% 1541
2023
Q2 		– Sell
-6,056
Closed -$82.4K – 1668
2023
Q1 		$82.4K Buy
6,056
+1,530
+34% +$27.4K 0.03% 882
2022
Q4 		$88.4K Buy
4,526
+151
+3% +$2.95K 0.03% 834
2022
Q3 		$83K Buy
4,375
+3,656
+508% +$84.2K 0.04% 736
2022
Q2 		$15K Buy
719
+709
+7,090% +$16.8K 0.01% 1540
2022
Q1 		$0 Buy
10
+2
+25% +$73 ﹤0.01% 1906
2021
Q4 		$0 Sell
8
-1
-11% -$33 ﹤0.01% 1914
2021
Q3 		$0 Sell
9
-4
-31% -$105 ﹤0.01% 1271
2021
Q2 		$0 Buy
13
+7
+117% +$167 ﹤0.01% 1191
2021
Q1 		$0 Buy
+6
New +$217 ﹤0.01% 526

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

State of Wyoming's ITOS Position: Q4 2024 in Review

State of Wyoming sold out of iTeos Therapeutics (ITOS) in Q4 2024, closing a stake of 3,320 shares — an estimated $33.9K sold.

State of Wyoming first reported a position in ITOS in Q1 2021 and held it in 10 quarters. The position peaked at $88.4K in Q4 2022. 136 funds tracked by Wall St. Rank hold ITOS as of Q4 2024.

  • State of Wyoming reported no remaining iTeos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • State of Wyoming sold 3,320 iTeos Therapeutics shares in Q4 2024, an estimated $33.9K.
  • State of Wyoming first reported a position in iTeos Therapeutics in Q1 2021 and held it in 10 quarters.
  • State of Wyoming's iTeos Therapeutics position peaked at $88.4K in Q4 2022.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2024.

Based on State of Wyoming's 13F filing for Q4 2024, filed 14 Feb 2025.